Barbara Burtness, MD
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Barbara Burtness, MD is Professor of Medicine (Medical Oncology) at the Yale School of Medicine and Interim Associate Director for Diversity, Equity and Inclusion at the Yale Cancer Center. She serves as Co-Leader of the Developmental Therapeutics Program, Leader of the Disease Aligned Research for Head and Neck Cancer, and Director of the Yale Head and Neck Specialized Program of Research Excellence. Dr. Burtness is internationally recognized for her research in head and neck cancer. She chairs the ECOG-ACRIN Cooperative Group Head and Neck Cancer Therapeutics Committee, and leads national and international trials of targeted therapy in head and neck cancer. Her laboratory studies synthetic lethal therapeutic strategies in head and neck cancer and the targeting of aurora kinase A to overcome adaptive resistance to EGFR inhibition and - in lung cancer- to direct KRAS inhibition.
Education & Training
- FellowshipMemorial Sloan Kettering Cancer Center (1993)
- ResidencyYale-New Haven Hospital (1989)
- InternshipYale-New Haven Hospital (1987)
- MDSUNY at Stonybrook (1986)
- ABBryn Mawr College (1982)
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
Robert L. Krigel Award, Excellence in Teaching and Clinical Oncology | Fox Chase Cancer Center | 2012 |
Top Doctor | U.S. News and World Report | |
Best Doctors in America | Best Doctors |
Professional Service
Organization | Role | Date |
---|---|---|
ECOG-ACRIN | Chair of the ECOG-ACRIN Head and Neck Therapeutics Committee | 2006 - Present |
Departments & Organizations
- Developmental Therapeutics
- Diversity, Equity, and Inclusion
- Head and Neck Cancers Program
- Internal Medicine
- K12 Calabresi Immuno-Oncology Training Program (IOTP)
- Medical Oncology
- Status of Women in Medicine Committee (SWIM)
- Subset Medical Oncology Faculty
- Yale Cancer Center
- Yale Center for Immuno-Oncology
- Yale CTAP
- Yale Medicine